[Federal Register: August 31, 1999 (Volume 64, Number 168)]
[Notices]               
[Page 47507-47508]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr31au99-94]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
National Vaccine Advisory Committee, Subcommittee on Future 
Vaccines, Subcommittee on Immunization Coverage, and Subcommittee on 
Vaccine Safety and Communication Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 9 a.m.-2 p.m., September 16, 1999; 8:30 a.m.-
12:45 p.m., September 17, 1999.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Notice: In the interest of security, the Department has 
instituted stringent procedures for entrance to the Hubert H. 
Humphrey Building by non-government employees. Thus, persons without 
a government identification card should plan to arrive at the 
building each day either between 8 and 8:30 a.m. or 12:30 and 1 p.m. 
Entrance to the meeting at other times during the day cannot be 
assured.
    Purpose: This committee advises and makes recommendations to the 
Director of the National Vaccine Program on matters related to the 
Program responsibilities.
    Matters To Be Discussed: Agenda items will include: an update on 
the National Vaccine Program Office (NVPO) activities; a workshop 
report on thimerasol in vaccines; an update on rotavirus vaccine 
recommendations; an update on the Vaccine Safety and Communication 
Subcommittee; decision making and communication issues in vaccine 
safety; an update on the immunization registries initiative; reports 
from the Future Vaccines Subcommittee, Vaccine Safety and 
Communication Subcommittee and the Immunization Coverage 
Subcommittee; an update on pandemic preparedness planning; and 
discussions on immunization challenges in Mexico and Canada.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
    Place: Hubert H. Humphrey Building, Room 305A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee develops policy options and guides 
national activities that lead to accelerated development, licensure, 
and the best use of new vaccines in the simplest possible 
immunization schedules.
    Matters To Be Discussed: Agenda items will include discussions 
regarding the Institute of Medicine (IOM) report concerning 
cytomegalovirus vaccines and the IOM report concerning enteric 
bacteria vaccines.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
    Place: Hubert H. Humphrey Building, Room 505A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee will identify and propose solutions 
that provide a multifaceted and holistic approach to reducing 
barriers that result in low immunization coverage for children.
    Matters To Be Discussed: Agenda items will include updates on 
the roll out process for the ``Strategies to Sustain Success'' 
initiative; the status of the paper on adult immunizations at non-
traditional sites and standards for adult immunizations at non-

[[Page 47508]]

traditional sites; and, adolescent immunizations. The subcommittee 
will also discuss revisions of adult immunization standards in 
conjunction with the National Coalition for Adult Immunization; and 
assessment of vaccine coverage in view of recent vaccine safety 
issues.

    Name: Subcommittee on Vaccine Safety and Communication.
    Time and Date: 2:45 p.m.-5 p.m., September 16, 1999.
    Place: Hubert H. Humphrey Building, Room 325A, 200 Independence 
Avenue, SW, Washington, DC 20201.
    Status: Open to the public, limited only by the space available.
    Purpose: This subcommittee reviews issues relevant to vaccine 
safety and adverse reactions to vaccines.
    Matters To Be Discussed: Agenda items include a discussion on 
Thimerosal in vaccines, rotavirus vaccine and intussusception and 
the private governmental communications/response to acute vaccine 
safety issues.
    Agenda items are subject to change as priorities dictate.

CONTACT PERSON FOR MORE INFORMATION: Gloria Sagar, Committee Management 
Specialist, NVPO, CDC, 1600 Clifton Road, NE, M/S A-11, Atlanta, 
Georgia 30333, telephone 404/639-4450.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities for 
both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: August 24, 1999.
John C. Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 99-22525 Filed 8-30-99; 8:45 am]
BILLING CODE 4163-18-P